Publications by authors named "Mark Oppe"

Claim this Profile
H
How do Design Characteristics Affect Respondent Engagement? Assessing Attribute Non-attendance in Discrete Choice Experiments Valuing the EQ-5D-5L.
Peiwen Jiang, Deborah Street, Richard Norman, Rosalie Viney, Mark Oppe

Patient· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy.
Berend J van der Wilk, Ben M Eyck, Bo J Noordman, Leonieke W Kranenburg, Mark Oppe

Ann Surg Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health state utilities for beta-thalassemia: a time trade-off study.
Antony P Martin, Enrico Ferri Grazzi, Claudia Mighiu, Manoj Chevli, Farrukh Shah, Mark Oppe

Eur J Health Econ· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France.
Mark Oppe, Bogdan Muresan, Katie Chan, Xenia Radu, Bob G Schultz

Expert Rev Pharmacoecon Outcomes Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain.
Anabel Estévez-Carrillo, Sarah Dewilde, Mark Oppe, Juan M Ramos-Goñi

Patient· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
Juan M Ramos-Goñi, Anabel Estévez-Carrillo, Oliver Rivero-Arias, Donna Rowen, David Mott, Mark Oppe

Value Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada.
Elisabetta Fenu, Vasily Lukyanov, Annabel Acs, Xenia Radu, Stephanie Stypa, Mark Oppe

Pharmacoecon Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands.
Steef Redeker, Sohal Ismail, Hester V Eeren, Emma K Massey, Willem Weimar, Mark Oppe

Eur J Health Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.
Juan M Ramos-Goñi, Mark Oppe, Anabel Estévez-Carrillo, Oliver Rivero-Arias,

Value Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms.
Koonal K Shah, Bryan Bennett, Andrew Lenny, Louise Longworth, John E Brazier, Mark Oppe

Eur J Health Econ· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To What Extent Do Patient Preferences Differ From General Population Preferences?
Kristina Ludwig, Juan M Ramos-Goñi, Mark Oppe, Simone Kreimeier, Wolfgang Greiner

Value Health· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses.
Mark Oppe, Daniela Ortín-Sulbarán, Carlos Vila Silván, Anabel Estévez-Carrillo, Juan M Ramos-Goñi

Eur J Health Econ· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life after traumatic brain injury: deriving value sets for the QOLIBRI-OS for Italy, The Netherlands and The United Kingdom.
Daphne C Voormolen, Suzanne Polinder, Nicole von Steinbuechel, Yan Feng, Lindsay Wilson, Mark Oppe

Qual Life Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Valuation Protocol for the EQ-5D-Y-3L.
Juan M Ramos-Goñi, Mark Oppe, Elly Stolk, Koonal Shah, Simone Kreimeier

Pharmacoeconomics· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A French Value Set for the EQ-5D-5L.
Luiz Flavio Andrade, Kristina Ludwig, Juan Manuel Ramos Goni, Mark Oppe, Gérard de Pouvourville

Pharmacoeconomics· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a Smaller Design for EQ-5D-5L Valuation Studies.
Zhihao Yang, Nan Luo, Mark Oppe, Gouke Bonsel, Jan Busschbach

Value Health· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States Valuation of EQ-5D-5L Health States Using an International Protocol.
A Simon Pickard, Ernest H Law, Ruixuan Jiang, Eleanor Pullenayegum, James W Shaw, Mark Oppe

Value Health· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L.
Martine Hoogendoorn, Mark Oppe, Melinde R S Boland, Lucas M A Goossens, Elly A Stolk

Med Decis Making· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a home-based group educational programme on renal replacement therapies: a study protocol.
Steef Redeker, Mark Oppe, Martijn Visser, Jan J V Busschbach, Willem Weimar

BMJ Open· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity-Stratified Discrete Choice Experiment Designs for Health State Evaluations.
Sesil Lim, Marcel F Jonker, Mark Oppe, Bas Donkers, Elly Stolk

Pharmacoeconomics· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Simone Kreimeier, Mark Oppe, Juan M Ramos-Goñi, Amanda Cole, Nancy Devlin

Value Health· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Issues and Potential Solutions for Understanding Healthcare Preference Heterogeneity Free from Patient-Level Scale Confounds.
Catharina G M Groothuis-Oudshoorn, Terry N Flynn, Hong Il Yoo, Jay Magidson, Mark Oppe

Patient· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
Juan M Ramos-Goñi, Benjamin M Craig, Mark Oppe, Yolanda Ramallo-Fariña, Jose Luis Pinto-Prades

Value Health· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis